Asymmetry Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Asymmetry Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$6.44M	Buy
2021 Q3	$7.43M	Sell
2021 Q2	$9.37M	Buy
2021 Q1	$4.16M	Buy
2020 Q1	–	Sell
2019 Q4	$896K	Buy